Ifp Advisors, Inc Amgen Inc Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Amgen Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 9,006 shares of AMGN stock, worth $2.36 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

9,006

Previous 4,131 118.01%

Holding current value

$2.36 Million

Previous $1.17 Million 139.61%

% of portfolio

0.12%

Previous 0.05%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $1.28 Million - $1.56 Million	4,875 Added 118.01%	9,006 $2.81 Million
Q1 2024 Jul 30, 2024	BUY	$268.87 - $324.56 $36,028 - $43,491	134 Added 3.35%	4,131 $1.17 Million
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $41,934 - $47,307	-164 Reduced 3.94%	3,997 $1.15 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $453,917 - $563,550	-2,076 Reduced 33.29%	4,161 $1.12 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $9,642 - $11,401	45 Added 0.73%	6,237 $1.38 Million
Q1 2023 Apr 18, 2023	SELL	$225.79 - $275.2 $1.17 Million - $1.42 Million	-5,165 Reduced 45.48%	6,192 $1.5 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $34,812 - $44,233	-152 Reduced 1.32%	11,357 $1.78 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $331,078 - $373,396	1,475 Added 14.7%	11,509 $1.8 Million
Q2 2022 Sep 06, 2022	BUY	$230.71 - $256.74 $2.3 Million - $2.56 Million	9,959 Added 13278.67%	10,034 $1.56 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $2.3 Million - $2.56 Million	-9,959 Reduced 99.25%	75 $12,000
Q1 2022 Sep 06, 2022	BUY	$219.27 - $242.57 $1.02 Million - $1.12 Million	4,630 Added 85.68%	10,034 $2.43 Million
Q1 2022 Aug 08, 2022	BUY	$219.27 - $242.57 $80,472 - $89,023	367 Added 7.29%	5,404 $1.31 Million
Q4 2021 Jan 12, 2022	SELL	$198.88 - $227.6 $46,537 - $53,258	-234 Reduced 4.44%	5,037 $1.14 Million
Q3 2021 Oct 06, 2021	BUY	$212.27 - $248.7 $341,117 - $399,660	1,607 Added 43.86%	5,271 $1.13 Million
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $78,249 - $86,811	335 Added 10.06%	3,664 $895,000
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $147,348 - $171,710	-664 Reduced 16.63%	3,329 $820,000
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $82,873 - $98,687	-383 Reduced 8.75%	3,993 $916,000
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $33,320 - $37,054	-142 Reduced 3.14%	4,376 $1.12 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $59,540 - $73,064	-301 Reduced 6.25%	4,518 $1.04 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $45,013 - $59,699	247 Added 5.4%	4,819 $957,000
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $131,500 - $169,024	695 Added 17.93%	4,572 $1.1 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $183,511 - $219,885	1,054 Added 37.34%	3,877 $757,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $2.02 Million - $2.28 Million	-11,180 Reduced 79.84%	2,823 $534,000
Q4 2018 Jan 23, 2019	SELL	$178.4 - $208.25 $344,668 - $402,339	-1,932 Reduced 12.12%	14,003 $2.73 Million
Q3 2018 Oct 25, 2018	BUY	$185.29 - $208.89 $124,144 - $139,956	670 Added 4.39%	15,935 $0
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $346,878 - $389,619	-2,089 Reduced 12.04%	15,265 $0
Q1 2018 Jun 03, 2019	BUY	$169.43 - $198.0 $152,317 - $178,002	899 Added 5.46%	17,354 $3.02 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $152,317 - $178,002	-899 Reduced 5.18%	16,455 $0
Q4 2017 Jan 24, 2018	SELL	$168.79 - $188.59 $765,125 - $854,878	-4,533 Reduced 20.71%	17,354 $0
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $34,963 - $39,919	209 Added 0.96%	21,887 $4.08 Million
Q2 2017 Jun 03, 2019	SELL	N/A	-1,993 Reduced 8.42%	21,678 $3.73 Million
Q1 2017 Jun 03, 2019	BUY	N/A	3,774 Added 18.97%	23,671 $3.88 Million
Q4 2016 Jun 03, 2019	BUY	N/A	5,811 Added 41.25%	19,897 $2.91 Million
Q2 2016 Jun 03, 2019	BUY	N/A	11,263 Added 398.97%	14,086 $2.14 Million
Q1 2016 Jun 03, 2019	BUY	N/A	2,823	2,823 $534,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account